Know Cancer

or
forgot password

Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction


N/A
3 Years
N/A
Not Enrolling
Both
Osteosarcoma

Thank you

Trial Information

Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction


Inclusion Criteria:



- Patients with osteosarcoma are the study group

- Patients with malignant diagnoses other than osteosarcoma, neuroblastoma, Ewing's
sarcoma or synovial sarcoma may participate as controls

- Histologically proven osteosarcoma or a history of histologically proven osteosarcoma
are eligible for participation. The patient does not need to be newly diagnosed for
enrollment on this protocol

- Patients with malignant diagnosis other than osteosarcoma, neuroblastoma, Ewing's
sarcoma or synovial sarcoma are eligible to participate if they have a central venous
catheter and routine blood work is being drawn

Exclusion Criteria:

- Patients less then three years of age

- Patients with Ewing's sarcoma, neuroblastoma and synovial sarcoma will be excluded
from this protocol

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To determine if circulating osteosarcoma cells can be reliably detected and quantitated in the blood of patients with localized and advanced osteosarcoma.

Outcome Time Frame:

conclusion of the study

Safety Issue:

No

Principal Investigator

Paul Meyers, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

99-120

NCT ID:

NCT00588510

Start Date:

January 2000

Completion Date:

September 2011

Related Keywords:

  • Osteosarcoma
  • Sarcoma
  • Bone
  • Osteosarcoma

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021